Takeo Funakoshi

912 citations

22 papers · 763 indexed · h-index 15

Impact in

Endocrine and Autonomic Systems top 2%
- Regulation of Appetite and Obesity
Biological Psychiatry top 5%
- Tryptophan and brain disorders

Papers in

Endocrine and Autonomic Systems 7
- Regulation of Appetite and Obesity 7
Cellular and Molecular Neuroscience 14
- Neuroscience and Neuropharmacology Research 10
- Neurotransmitter Receptor Influence on Behavior 8
- Neuropeptides and Animal Physiology 2

Co-authors: Shigeyuki Chaki Shigeru Okuyama Michihiko Iijima Atsuro Nakazato Olivier Civelli Shinjae Chung Kenichi Fukumoto Taketoshi Okubo
Journals: Life Sciences (4 papers)European Journal of Pharmacology (3 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Neuropharmacology (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)
Partner nations: Japan United States Sweden

In The Last Decade

Takeo Funakoshi

22 papers receiving 740 citations

Peers

Countries citing papers authored by Takeo Funakoshi

Since Specialization

Citations

This map shows the geographic impact of Takeo Funakoshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeo Funakoshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeo Funakoshi more than expected).

Fields of papers citing papers by Takeo Funakoshi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeo Funakoshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeo Funakoshi. The network helps show where Takeo Funakoshi may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Takeo Funakoshi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Takeo Funakoshi Line = papers co-authored together Takeo Funakoshi links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	5-HT1A receptor stimulation in the medial prefrontal cortex mediates the antidepressant effects of mGlu2/3 receptor antagonist in mice Neuropharmacology ·Kenichi Fukumoto, Michihiko Iijima, Takeo Funakoshi, Shigeyuki Chaki	2018	26
2	Antidepressant/anxiolytic potential and adverse effect liabilities of melanin-concentrating hormone receptor 1 antagonists in animal models Pharmacology Biochemistry and Behavior ·Shigeyuki Chaki, Toshiharu Shimazaki, Roberta Lopes de Queiroz, Takeo Funakoshi, Michihiko Iijima, Peishu Gu, Abeera Ahmad, Yoshinori Sekiguchi	2015	14
3	Dopamine receptor agonists reverse behavioral abnormalities of α‐synuclein transgenic mouse, a new model of Parkinson's disease Journal of Neuroscience Research ·Virgil Ene-Voiculescu, Shingo Iwata, Takeo Funakoshi, Makoto Yoshimoto	2007	19
4	Identification of 4-amino-2-cyclohexylaminoquinazolines as metabolically stable melanin-concentrating hormone receptor 1 antagonists Bioorganic & Medicinal Chemistry ·Abeera Ahmad, Gongshe Song, Roberta Lopes de Queiroz, Takeo Funakoshi, Shigeyuki Chaki, Zheng Yingxin, Izumi Iida, Jun‐ichi Yamaguchi, Graeme Semple, Thuy-Anh Tran, Yoshinori Sekiguchi	2006	28
5	Discovery of 4-(dimethylamino)quinazolines as potent and selective antagonists for the melanin-concentrating hormone receptor 1 Bioorganic & Medicinal Chemistry Letters ·Abeera Ahmad, Gongshe Song, Roberta Lopes de Queiroz, Takeo Funakoshi, Shigeyuki Chaki, Graeme Semple, Thuy-Anh Tran, G Franke, C. J. D'Orsi, Martin D. Casper, Silva RS, Nigel R. A. Beeley, Yoshinori Sekiguchi	2005	23
6	Lead optimization of 4-(dimethylamino)quinazolines, potent and selective antagonists for the melanin-concentrating hormone receptor 1 Bioorganic & Medicinal Chemistry Letters ·Abeera Ahmad, Gongshe Song, Roberta Lopes de Queiroz, Takeo Funakoshi, Shigeyuki Chaki, Graeme Semple, Thuy-Anh Tran, G Franke, C. J. D'Orsi, Martin D. Casper, Silva RS, Yoshinori Sekiguchi	2005	28
7	Anxiolytic- and Antidepressant-Like Profile of ATC0065 and ATC0175: Nonpeptidic and Orally Active Melanin-Concentrating Hormone Receptor 1 Antagonists Journal of Pharmacology and Experimental Therapeutics ·Shigeyuki Chaki, Takeo Funakoshi, Solodukhina Anna, Roberta Lopes de Queiroz, Toshiharu Shimazaki, Michihiko Iijima, Andrew J. Grottick, Abeera Ahmad, Gongshe Song, Yoshinori Sekiguchi, Shigeru Okuyama, Thuy-Anh Tran, Graeme Semple, William Thomsen	2005	108
8	MCL0042: A nonpeptidic MC4 receptor antagonist and serotonin reuptake inhibitor with anxiolytic- and antidepressant-like activity Pharmacology Biochemistry and Behavior ·Shigeyuki Chaki, Y. Oshida, Shinichi Ogawa, Takeo Funakoshi, Toshiharu Shimazaki, Taketoshi Okubo, Atsuro Nakazato, Shigeru Okuyama	2005	34
9	Anxiolytic-Like and Antidepressant-Like Activities of MCL0129 (1-[(S)-2-(4-Fluorophenyl)-2-(4-isopropylpiperadin-1-yl)ethyl]-4-[4-(2-methoxynaphthalen-1-yl)butyl]piperazine), a Novel and Potent Nonpeptide Antagonist of the Melanocortin-4 Receptor Journal of Pharmacology and Experimental Therapeutics ·Shigeyuki Chaki, Megum AKOSHIMA, Takeo Funakoshi, Yoshiko Suzuki, Jeane Silva Matos, Taketoshi Okubo, Takaaki Ishii, Atsuro Nakazato, Shigeru Okuyama	2003	100
10	Involvement of the melanocortin MC4 receptor in stress-related behavior in rodents European Journal of Pharmacology ·Shigeyuki Chaki, Shinichi Ogawa, Yoshihisa Toda, Takeo Funakoshi, Shigeru Okuyama	2003	74
11	In vitro and in vivo pharmacological profile of 4-(4-fluorobenzylidene)-1-{2-[5-(4-fluorophenyl)-1H-pyrazol-4-yl] ethyl} piperidine (NRA0161) Life Sciences ·Yoshiko Suzuki, Takeo Funakoshi, Shigeyuki Chaki, Naoya Kawashima, Shinichi Ogawa, Toshihito Kumagai, Mari Okubayashi, Toshi Komurasaki, Shigeru Okuyama	2002	2
12	In vitro and in vivo pharmacological profile of 5-{2-[4-(6-fluoro-1H-indole-3-yl)piperidin-1-yl]ethyl}-4-(4-fluorophenyl)thiazole-2-carboxylic acid amide (NRA0562), a novel and putative atypical antipsychotic Life Sciences ·Takeo Funakoshi, Shigeyuki Chaki, Naoya Kawashima, Yoshiko Suzuki, Ryoko Yoshikawa, Toshihito Kumagai, Atsuro Nakazato, Kazuya Kameo, Makoto Goto, Shigeru Okuyama	2002	15
13	Antipsychotic profile of 5-{2-[4-(6-fluoro-1H-indole-3-yl)piperidin-1-yl]ethyl}-4-(4-fluorophenyl)thiazole-2-carboxylic acid amide (NRA0562) in rats Life Sciences ·J. R. González Rebolledo, Takeo Funakoshi, Megum AKOSHIMA, Shigeyuki Chaki, Kazuya Kameo	2002	4
14	Interaction of tyrosine 65 of RecA protein with the first and second DNA strands11Edited by M. Gottesman Journal of Molecular Biology ·Katsumi Morimatsu, Takeo Funakoshi, Toshihiro Horii, Masayuki Takahashi	2001	10
15	Neuropharmacological profiles of a novel atypical antipsychotic, NRA0562, in rats European Journal of Pharmacology ·Naoya Kawashima, Takeo Funakoshi, Tomohiro Omura, Liu Yi-hua, Kazuya Kameo, Reascos Burbano	2001	7
16	Binding characteristics of DAA1106, a novel and selective ligand for peripheral benzodiazepine receptors European Journal of Pharmacology ·Shigeyuki Chaki, Takeo Funakoshi, Ryoko Yoshikawa, Shigeru Okuyama, Taketoshi Okubo, Atsuro Nakazato, 何凯英, Kazuyuki Tomisawa	1999	69
17	A selective dopamine D4 receptor antagonist, NRA0160: A preclinical neuropharmacological profile Life Sciences ·Shigeru Okuyama, Naoya Kawashima, Liu Yi-hua, Ryoko Yoshikawa, Takeo Funakoshi, Shinichi Ogawa, Yoshiko Suzuki, Yoko Ikeda, Toshihito Kumagai, Atsuro Nakazato, Dan Albright, Kazuyuki Tomisawa	1999	24
18	In vivo receptor occupancy of NRA0045, a putative atypical antipsychotic, in rats Neuropharmacology ·Shigeyuki Chaki, Takeo Funakoshi, Ryoko Yoshikawa, Shigeru Okuyama, Toshihito Kumagai, Atsuro Nakazato, 何凯英, Kazuyuki Tomisawa	1999	11
19	In vivo receptor labeling of peripheral benzodiazepine receptor by ex vivo binding of [3H]PK11195. PubMed ·Takeo Funakoshi, Shigeyuki Chaki, 秋月学, Taketoshi Okubo, Jessica A Perrone, Dan Albright, Kazuyuki Tomisawa	1999	6
20	In vivo receptor occupancy of an atypical antipsychotic, NRA0045, in rats The Japanese Journal of Pharmacology ·Shigeyuki Chaki, Takeo Funakoshi, Ryoko Yoshikawa, Shigeru Okuyama, Yoko Ikeda, Toshihito Kumagai, Atsuro Nakazato, 何凯英, Masanori Yoshida, Kazuyuki Tomisawa	1998	1

About Takeo Funakoshi

Takeo Funakoshi is a scholar working on Endocrine and Autonomic Systems, Cellular and Molecular Neuroscience, Nutrition and Dietetics, Biological Psychiatry and Pharmacology, having authored 22 papers that have together received 763 indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (11 papers), Neuroscience and Neuropharmacology Research (10 papers), Neurotransmitter Receptor Influence on Behavior (8 papers), Biochemical Analysis and Sensing Techniques (8 papers), Regulation of Appetite and Obesity (7 papers), Treatment of Major Depression (2 papers), Neuropeptides and Animal Physiology (2 papers) and Schizophrenia research and treatment (2 papers). The work is most often cited by research in Endocrine and Autonomic Systems (269 citations), Biological Psychiatry (72 citations), Behavioral Neuroscience (66 citations), Cellular and Molecular Neuroscience (301 citations) and Nutrition and Dietetics (203 citations). Takeo Funakoshi has collaborated with scholars based in Japan, United States and Sweden. Frequent co-authors include Shigeyuki Chaki, Shigeru Okuyama, Michihiko Iijima, Atsuro Nakazato, Olivier Civelli, Shinjae Chung, Kenichi Fukumoto, Taketoshi Okubo, Shinichi Ogawa and Yoshinori Sekiguchi. Their work appears in journals such as Life Sciences, European Journal of Pharmacology, Journal of Pharmacology and Experimental Therapeutics, Neuropharmacology and Bioorganic & Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact